Profilo
Attualmente, Terry-Ann Burrell ricopre la posizione di direttore finanziario e tesoriere di Beam Therapeutics, Inc. La signora Burrell è anche nel consiglio di amministrazione di Recursion Pharmaceuticals, Inc. Nella sua carriera passata ha occupato la posizione di amministratore delegato presso JPMorgan Securities LLC. La signora Burrell ha conseguito una laurea presso l'Università di Harvard e un MBA presso la Leonard N Stern School of Business.
Precedenti posizioni note di Terry-Ann Burrell
| Società | Posizione | Fine |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 12/08/2024 |
| BEAM THERAPEUTICS INC. | Direttore Finanziario/CFO | 09/08/2024 |
| RAPPORT THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 08/08/2024 |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/08/2019 |
Formazione di Terry-Ann Burrell
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beam Therapeutics, Inc.
Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
















